🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the safety, efficacy and pharmaco...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-08-08
Trial ID
NCT05941585
Treatments Being Tested
Explore the efficacy and safety of mitoxantrone liposome combined with irin...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-07-03
Trial ID
NCT06514313
The purpose of the study is to examine the toxicity profile, maximum tolera...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT02043756
Treatments Being Tested
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
This is a prospective, open-label, single arm, multicenter clinical study t...
Status
Unknown
Location
Beijing Hospital
Start Date
2022-05-01
Trial ID
NCT05441761
Treatments Being Tested
This is a single-center, open, randomized parallel group design study to in...
Status
Completed
Location
Guizhou Cancer Hospita
Start Date
2019-07-29
Trial ID
NCT05173545
Treatments Being Tested
This is an open-label, multicenter, randomized, phase 3 trial to evaluate t...
Status
Unknown
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical University
Start Date
2022-02-15
Trial ID
NCT05244642
Treatments Being Tested
This is a multicenter, open-label, single-arm, phase Ib study to evaluate t...
Status
Terminated
Location
Beijing Luhe Hospital Capital Medical University
Start Date
2021-03-30
Trial ID
NCT04718402
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This is a multicentre, open-label, single-arm, phase I/II clinical study to...
Status
Terminated
Location
the Affiliated Cancer Hospital of Guizhou Medical University
Start Date
2020-09-15
Trial ID
NCT04509466